Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Quiroga

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Alimentary Pharmacology & Therapeutics|July 1, 2004
Pegylated interferon-alpha2a kinetics during experimental haemodialysis: impact of permeability and pore size of dialysersG Barril, J A Quiroga, P Sanz, et al.
Journal of Hepatology|November 1, 1989
Treatment of chronic delta infection with recombinant human interferon alpha 2c at high dosesJ C Porres, V Carreño, J Bartolomé, et al.
The American Journal of Gastroenterology|April 25, 2001
Association of HLA-DR genes with mild idiopathic adulthood biliary ductopeniaM E García-Jiménez, J A Quiroga, M L Gutiérrez, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 13, 2000
Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding riskM L Manzano, C Arocena, J F Tomás, et al.
Journal of Hepatology|January 1, 1990
Prolonged treatment (18 months) of chronic hepatitis C with recombinant alpha-interferon in comparison with a control groupM Gómez-Rubio, J C Porres, I Castillo, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 1, 1997
Tolerance and efficacy of subcutaneous interferon-beta administered for treatment of chronic hepatitis CA Castro, E Carballo, A Domínguez, et al.
Lancet (London, England)|June 18, 1994
Retreatment of chronic hepatitis C virus infectionM Pardo, T Cotonat, M Herrero, et al.
Gastroenterology|October 1, 1992
Immunoglobulin M antibody to hepatitis C virus during interferon therapy for chronic hepatitis CJ A Quiroga, O Bosch, R Gonzalez, et al.
Hepatology (Baltimore, Md.)|July 1, 1991
IgM antibody to hepatitis C virus in acute and chronic hepatitis CJ A Quiroga, M L Campillo, I Catillo, et al.
Digestion|January 1, 1991
Detection of antibody to calmodulin in chronic viral hepatitis: lack of correlation with virus replication and hepatocellular damageA Díez, J A Quiroga, M Melero, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Alimentary Pharmacology & Therapeutics|July 1, 2004
Pegylated interferon-alpha2a kinetics during experimental haemodialysis: impact of permeability and pore size of dialysersG Barril, J A Quiroga, P Sanz, et al.
Journal of Hepatology|November 1, 1989
Treatment of chronic delta infection with recombinant human interferon alpha 2c at high dosesJ C Porres, V Carreño, J Bartolomé, et al.
The American Journal of Gastroenterology|April 25, 2001
Association of HLA-DR genes with mild idiopathic adulthood biliary ductopeniaM E García-Jiménez, J A Quiroga, M L Gutiérrez, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 13, 2000
Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding riskM L Manzano, C Arocena, J F Tomás, et al.
Journal of Hepatology|January 1, 1990
Prolonged treatment (18 months) of chronic hepatitis C with recombinant alpha-interferon in comparison with a control groupM Gómez-Rubio, J C Porres, I Castillo, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 1, 1997
Tolerance and efficacy of subcutaneous interferon-beta administered for treatment of chronic hepatitis CA Castro, E Carballo, A Domínguez, et al.
Lancet (London, England)|June 18, 1994
Retreatment of chronic hepatitis C virus infectionM Pardo, T Cotonat, M Herrero, et al.
Gastroenterology|October 1, 1992
Immunoglobulin M antibody to hepatitis C virus during interferon therapy for chronic hepatitis CJ A Quiroga, O Bosch, R Gonzalez, et al.
Hepatology (Baltimore, Md.)|July 1, 1991
IgM antibody to hepatitis C virus in acute and chronic hepatitis CJ A Quiroga, M L Campillo, I Catillo, et al.
Digestion|January 1, 1991
Detection of antibody to calmodulin in chronic viral hepatitis: lack of correlation with virus replication and hepatocellular damageA Díez, J A Quiroga, M Melero, et al.
Pageof 11